(Q44255490)

1 December 2017

Characterization of hepatic mitochondrial injury induced by fatty acid oxidation inhibitors (English)

1 reference

1 December 2017

0 references

Alison E M Vickers

1

1 reference

PubMed ID

19234235

1 December 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

1 December 2017

Toxicologic Pathology

1 reference

1 December 2017

37

1 reference

1 December 2017

1

1 reference

1 December 2017

78-88

1 reference

Heterogeneity of toxicant response: sources of human variability

1 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

NMR-based metabonomic studies on the biochemical effects of commonly used drug carrier vehicles in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Down-regulation of acyl-CoA oxidase gene expression and increased NF-kappaB activity in etomoxir-induced cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Drug-induced mitochondrial toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Ribosomal proteins in cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Pharmacological strategies for reduction of lipid availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

First dose of potential new medicines to humans: how animals help

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Mechanisms of cytochrome P450 substrate oxidation: MiniReview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Mechanisms of drug-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Markers of mitochondrial biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Interactions of acyl carnitines with model membranes: a (13)C-NMR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Etomoxir, a fatty acid oxidation inhibitor, increases food intake and reduces hepatic energy status in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Suppression of hepatic fatty acid oxidation and food intake in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Metallothionein: an intracellular protein to protect against cadmium toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

The ribotoxic stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Metabolic manipulation in ischaemic heart disease, a novel approach to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Biochemical mechanisms of induction of hepatic peroxisome proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Metabolic agents in the management of diabetic coronary patients: a new era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Etomoxir-induced oxidative stress in HepG2 cells detected by differential gene expression is confirmed biochemically

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Concordance of the toxicity of pharmaceuticals in humans and in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Hepatotoxicity due to mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Metabolically-modulated growth and phenotype of the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Modeling tissue-specific signaling and organ function in three dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Putative function and physiological relevance of the mitochondrial uncoupling protein-3: involvement in fatty acid metabolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Mitochondria as a pharmacological target

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Cellular stress responses and molecular mechanisms of nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Precision-cut organ slices to investigate target organ injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Clusterin is a secreted mammalian chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Over-expression of Candida albicans mitochondrial ribosomal protein S9 (MrpS9p) disturbs mitochondrial function in Saccharomyces cerevisiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Nuclear Magnetic Resonance Spectroscopic and Principal Components Analysis Investigations into Biochemical Effects of Three Model Hepatotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

Mitochondrial Glutathione: Importance and Transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308329285

21 January 2018

Identifiers

DOI

10.1177/0192623308329285

1 reference

1 December 2017

1 reference

PubMed ID

19234235